Journals / Ahi Evran Tıp Dergisi / 2022 / Cilt: 6 Sayı: 1

Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus

Tip 2 Diabetes Mellitus Penceresinden Metabolik Sendromlu Hastalarda Bilişsel Fonksiyonlar ve Zeka Katsayısı

Pages
1–6
Publication Date
2022-04-22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, even though DM presence has been shown to be a worsening factor on intelligence in MetS, further studies are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the cognitive functions and intelligence quotient (IQ) in patients with metabolic syndrome (MetS) by also considering Type 2 diabetes mellitus (DM).Materials and Methods: A cross‑sectional study was conducted from January to March 2020.
📊
Key Findings & Data:A total of 80 patients (44 patients with MetS and 36 patients without MetS), 18-75 years old, were recruited to the study consecutively.Clinical and laboratory parameters, Mini Mental State Examination (MMSE) and Kent E-G-Y scores of patients were measured.
💡
Conclusion & Impact:However, even though DM presence has been shown to be a worsening factor on intelligence in MetS, further studies are needed.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Bilişsel İşlev · Zekâ katsayısı · Metabolik sendrom

Abstract

Purpose: To evaluate the cognitive functions and intelligence quotient (IQ) in patients with metabolic syndrome (MetS) by also considering Type 2 diabetes mellitus (DM).Materials and Methods: A cross‑sectional study was conducted from January to March 2020. Participants in this study are from a tertiary care hospital. Patients admitted to the outpatient clinic with health check-up, or follow-up of DM were included in the study. A total of 80 patients (44 patients with MetS and 36 patients without MetS), 18-75 years old, were recruited to the study consecutively.Clinical and laboratory parameters, Mini Mental State Examination (MMSE) and Kent E-G-Y scores of patients were measured. Results: Glycated hemoglobin (HbA1c) and triglycerides levels were higher, whereas high-density lipoprotein-cholesterol (HDL-c) and ferritin levels were lower in patients with MetS. MMSE score was lower in participants with MetS than without MetS, whereas Kent E-G-Y score was similar in both groups. Depending on whether all patients have DM and/or MetS, subgroup analyzes were performed and evaluated. Patients with diabetes had lower IQ scores compared to the other subgroups. Conclusion: MetS reduces cognitive functions, whereas it has been shown that this generally does not have any effect on IQ. However, even though DM presence has been shown to be a worsening factor on intelligence in MetS, further studies are needed.

Özet

Amaç: Metabolik sendrom (MetS) olan hastalarda bilişsel işlevleri ve zeka katsayısı (IQ) değerini, tip 2 diabetes mellitus (DM) hastalığını dikkate alarak değerlendirmek.Araçlar ve Yöntem: Ocak-Mart 2020 tarihleri arasında kesitsel bir çalışma yürütüldü. Bu çalışmaya katılanlar üçüncü basamak bir hastanedendir. Sağlık kontrolü veya DM takibi ile polikliniğe başvuran hastalar çalışmaya dahil edildi. Çalışmaya 18-75 yaşlarında toplam 80 hasta (44 MetS'li ve 36 MetS'siz hasta) art arda dahil edildi. Hastaların klinik ve laboratuvar parametreleri, Mini MentalDurum Muayenesi (MMSE) ve Kent E-G-Y skorları ile ölçüldü.Bulgular: MetS'li hastalarda glikozile hemoglobin (HbA1c) ve trigliserid düzeyleri daha yüksek, yüksek dansiteli lipoprotein-kolesterol (HDL-c) ve ferritin düzeyleri daha düşüktü. MMSE skoru MetS'li katılımcılarda MetS'siz katılımcılardan daha düşükken, Kent E-G-Y skoru her iki grupta da benzerdi. Tüm hastaların DM ve/veya MetS olup olmadığına bağlı olarak, alt grup analizleri yapıldı vedeğerlendirildi. Diyabetli hastalar, diğer alt gruplara kıyasla daha düşük IQ puanlarına sahipti.Sonuç: MetS, bilişsel işlevleri azaltır, ancak bunun genel olarak IQ üzerinde bir etkisi olmadığı gösterilmiştir. Bununla birlikte, DM varlığının MetS’lu hastalarda zeka üzerine kötüleştiren bir faktör olduğu gösterilmiş olsa da, daha fazla çalışmaya ihtiyaç vardır.

🔖

Cite This Article

TOPALOĞLU, U. S., DEVECİ, K., GÖL, M. F., KIZILTEPE, M., ULUSOY, E., ULUSOY, D. M., SİMİTCİ, B. (2022). Cognitive Functions and Intelligence Quotient in Patients with Metabolic Syndrome Through the Window of Type 2 Diabetes Mellitus. Ahi Evran Tıp Dergisi, Cilt: 6 Sayı: 1, 1–6. https://ajindex.com/articles/898571

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Brandão AD, da Silva JH, Mariane Oliveira Lima S, et al. Short and long term effect of treatment non-pharmacological and lifestyle in patients with metabolic syndrome. Diabetol Metab Syndr. 2020;12(1):1-8
  2. Gül Yurdakul F, Bodur H, Öztop Çakmak Ö, et al. On the severity of carpal tunnel syndrome: diabetes or metabolic syndrome. J Clin Neurol. 2015;11(3):234-240
  3. Alalwan TA, Perna S, Mandeel QA, et al. Effects of daily low-dose date consumption on glycemic control, lipid profile, and quality of life in adults with pre- and type 2 diabetes: a randomized controlled trial. Nutrients. 2020;12(1):217
  4. Vanleerberghe P, De Witte N, Claes C, Schalock RL, Verté D. The quality of life of older people aging in place: a literature review. Qual Life Res. 2017;26(11):2899-2907
  5. Shin HY, Han HJ, Shin DJ, Park HM, Lee YB, Park KH. Sleep problems associated with behavioral and psychological symptoms as well as cognitive functions in Alzheimer's disease. J Clin Neurol. 2014;10(3):203-209
  6. Ghafoor H, Ahmad RA, Nordbeck P, Ritter O, Pauli P, Schulz SM. A cross-cultural comparison of the roles of emotional intelligence, metacognition, and negative coping for health-related quality of life in German versus Pakistani patients with chronic heart failure. Br J Health Psychol. 2019;24(4):828-846
  7. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the ınternational diabetes federation task force on epidemiology and prevention; national heart, lung, and blood ınstitute; american heart association; world heart federation; ınternational atherosclerosis society; and ınternational association for the study of obesity. Circulation. 2009;120(16):1640-1645
  8. American Diabetes Association. Standards of medical care in diabetes-2019. Diabetes Care. 2020;42(1):13-18
  9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198
  10. Katz L, Crook GH. Use of the kent E-G-Y with an aged population. J Gerontol. 1962;17(2):186-189
  11. Cohen E, Margalit I, Goldberg E, Krause I. Gender as an ındependent risk factor for the components of metabolic syndrome among ındividuals within the normal range of body mass ındex. Metab Syndr Relat Disord. 2018;16(10):537-542
  12. Kumbasar B, Yenigun M, Ataoglu HE, et al. The prevalence of metabolic syndrome in different ethnic groups in Turkey. J Int Med Res. 2013;41(1):188